No Data
Two Sessions Time | National People's Congress Representative, Lu Qingguo from Chenguang Biotech Group: Improve the quality standards of Chinese Patent Medicine, regulate the centralized procurement model for Traditional Chinese Medicine, and optimize the
① Lu Qingguo, Director of Chenguang Biotech Group and a representative of the National People's Congress, focused on several recommendations at this year's Two Sessions, including optimizing the procurement mechanism for Traditional Chinese Medicine, enhancing the quality standards for Chinese Patent Medicine, and standardizing the Traditional Chinese Medicine granule industry; ② In addition to recommendations related to the Traditional Chinese Medicine industry, Lu Qingguo prepared several suggestions on rural social retirement insurance, rural medical insurance, and increasing support for companies sanctioned by the United States.
Xinlong Holdings: 2024 Annual Results Forecast
Xinlong Holding(Group)Company (000955.SZ): Expected loss of 12.5 million yuan to 17.5 million yuan in 2024.
On January 21, Gelonghui reported that Xinlong Holding(Group)Company (000955.SZ)预计 expects a loss of 12.5 million to 17.5 million yuan in 2024, with a non-recurring loss of 17 million to 22 million yuan. In 2024, the company's overall Operation performance is steadily improving, significantly reducing losses compared to the previous year, mainly due to the company's commitment to annual Operation objectives, capturing favorable market changes and technological evolution trends, achieving results in the development of new products and new customers, with a significant increase in the number of Orders and profitability levels at the Hainan base compared to the previous year. Additionally, the Hunan and Hubei bases have shown significant results in cost reduction and efficiency improvement, with losses improving considerably.
Xinglong Holding (Group) Company Ltd. (SZSE:000955) May Have Run Too Fast Too Soon With Recent 28% Price Plummet
Xinlong's Unit Loses Court Appeal Over Equipment Deal Dispute
Xinlong Holdings: Report for the third quarter of 2024
Xinglong Holding (Group) Company Ltd. (SZSE:000955) Shares May Have Slumped 26% But Getting In Cheap Is Still Unlikely
